Fick Meghan E, Messenger Kristen M, Vigani Alessio
Department of Clinical Sciences, North Carolina State University, Raleigh, NC.
Department of Molecular Biomedical Sciences, North Carolina State University, Raleigh, NC.
J Vet Emerg Crit Care (San Antonio). 2020 Mar;30(2):226-231. doi: 10.1111/vec.12931. Epub 2020 Mar 4.
To describe the efficacy of in-series hemoperfusion and hemodialysis in 2 dogs with carprofen overdose.
This report describes the treatment of 2 dogs following accidental carprofen overdoses who underwent a single in-series hemoperfusion and hemodialysis session. Serial serum carprofen concentrations were measured before, during, and after the session. The first patient's session lasted 5 hours, with the largest decrease in serum carprofen concentrations occurring during the first hour of treatment. The carprofen clearance during the following 4 hours of treatment decreased substantially compared to the first hour and was not different from the patient's intrinsic clearance of carprofen after the session was completed. Based on the findings from the first case, the second patient was treated with a 1 hour single hemoperfusion and hemodialysis session. Our results support the hypothesis that carprofen is not effectively removed by conventional hemodialysis and the efficacy of hemoperfusion is short lived due to rapid saturation of the charcoal filter. Once filter saturation occurs, the extracorporeal session is no longer efficacious. Using in-series hemoperfusion and hemodialysis is of benefit to correct the side effects seen with hemoperfusion alone, and hourly charcoal filter replacement may extend the efficacy of treatment in removing carprofen.
This is the first published report of in-series hemoperfusion and hemodialysis being used to treat carprofen overdose in a dog. In these 2 cases, the intrinsic clearances of the patients were shown to be equivalent to that of standard hemodialysis alone, indicating that hemodialysis does not produce any advantage in carprofen clearance. In this limited report, we suggest that the efficacy of hemoperfusion in removing carprofen is short-lived, and extending the treatment beyond the first hour does not produce any therapeutic benefit. In order to extend the efficacy of hemoperfusion, hourly replacement of the charcoal filter should be considered.
描述串联血液灌流和血液透析对2只卡洛芬过量犬的疗效。
本报告描述了2只犬意外卡洛芬过量后接受单次串联血液灌流和血液透析治疗的情况。在治疗前、治疗期间和治疗后测量了卡洛芬的系列血清浓度。第一只犬的治疗持续了5小时,血清卡洛芬浓度在治疗的第一小时下降幅度最大。在接下来的4小时治疗中,卡洛芬清除率与第一小时相比大幅下降,且与治疗结束后犬的卡洛芬固有清除率无差异。基于第一例的结果,第二只犬接受了1小时的单次血液灌流和血液透析治疗。我们的结果支持以下假设:传统血液透析不能有效清除卡洛芬,且由于活性炭滤器快速饱和,血液灌流的疗效持续时间较短。一旦滤器饱和,体外治疗就不再有效。使用串联血液灌流和血液透析有助于纠正单独血液灌流所见的副作用,每小时更换活性炭滤器可能会延长卡洛芬清除治疗的疗效。
这是首次发表的关于串联血液灌流和血液透析用于治疗犬卡洛芬过量的报告。在这2例病例中,患者的固有清除率与单独标准血液透析的固有清除率相当,表明血液透析在卡洛芬清除方面没有任何优势。在这份有限的报告中,我们认为血液灌流清除卡洛芬的疗效是短暂的,治疗超过第一小时不会产生任何治疗益处。为了延长血液灌流的疗效,应考虑每小时更换活性炭滤器。